myristoyl glycine/histidine/lysine polypeptide hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

myristoyl glycine/histidine/lysine polypeptide hamilelikte güvenli mi?

No harmonised CLP classification, no SCCS or CIR safety assessment, and no reproducible animal or human reproductive/teratogenic data were identified for 'myristoyl glycine/histidine/lysine polypeptide' in the searched sources (ECHA C&L/Annex VI, SCCS/CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG). By default (CIR/SCCS absent and no harmonised flags), there is no evidence of reproductive hazard.

myristoyl glycine/histidine/lysine polypeptide emzirirken güvenli mi?

No data found indicating breastmilk transfer, lactation-specific toxicity, or classifications that would restrict use during breastfeeding. No mechanistic or in vivo evidence was identified to suggest a breastfeeding hazard in the searched authoritative sources.

myristoyl glycine/histidine/lysine polypeptide bebek cildi için güvenli mi?

No infant-specific safety or absorption studies located. Using the default approach (no evidence = 0), there is no identified reproductive/teratogenic hazard. Data on percutaneous absorption in adults or infants for this specific polypeptide were not found; therefore no exposure score increase was applied per the scoring rules.

VeriMom myristoyl glycine/histidine/lysine polypeptide nasıl puanlıyor?

VeriMom myristoyl glycine/histidine/lysine polypeptide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte myristoyl glycine/histidine/lysine polypeptide yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.